Biocon profile: Biocon is India's largest fully-integrated, innovation-led biopharmaceutical company that is driven by a passion to develop research-driven, cutting-edge therapies. The Company has taken the lead in India to harness the power of biotechnology through affordable innovation to find solutions that heal the world.
Over the years, Biocon has invested in cutting-edge science, key research partnerships and global manufacturing scale to develop products that address the various needs of patients worldwide. As an emerging global enterprise, Biocon is addressing the needs of patients through differentiated products in over 120 countries.
Biocon has invested majorly in cutting-edge research with the objective of reducing therapy costs for chronic conditions like diabetes, cancer and autoimmune diseases. The Company has successfully taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from 'Lab to Market'.